Relationship between Hypertension and Gut Microbiota: A Comprehensive Review

Ju Jiaxin; Tan Juanjuan; Cheng Caocao; Kang Yalong; Guan Fang; Wang Haifang

doi:10.23977/phpm.2024.040104

Relationship between Hypertension and Gut Microbiota: A Comprehensive Review

Download as PDF

DOI: 10.23977/phpm.2024.040104 | Downloads: 14 | Views: 234

Author(s)

Ju Jiaxin ¹, Tan Juanjuan ¹, Cheng Caocao ¹, Kang Yalong ¹, Guan Fang ¹, Wang Haifang ¹

Affiliation(s)

¹ Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China

Corresponding Author

Wang Haifang

ABSTRACT

Hypertension, one of the most common cardiovascular diseases, has become a global public health problem. The pathogenesis of hypertension has not been fully elucidated to date. Known risk factors for hypertension include atherosclerosis, obesity, dyslipidemia, among others. In addition, physical exercise, diet, traditional Chinese medicine, antibiotics and probiotics also play important roles in the occurrence and development of hypertension. Studies have shown that the gut microbiota can participate in the occurrence and development of hypertension through a series of processes involving the regulation of endocrine and host metabolism. This article provides a brief summary of the current understanding of the relationship between gut microbiota and the occurrence and development of hypertension, aiming to provide new insights for the diagnosis and treatment of hypertension in the future.

KEYWORDS

Hypertension; cardiovascular disease; gut microbiota; intestinal barrier function; traditional Chinese medicine

CITE THIS PAPER

Ju Jiaxin, Tan Juanjuan, Cheng Caocao, Kang Yalong, Guan Fang, Wang Haifang, Relationship between Hypertension and Gut Microbiota: A Comprehensive Review. MEDS Public Health and Preventive Medicine (2024) Vol. 4: 23-30. DOI: http://dx.doi.org/10.23977/phpm.2024.040104.

REFERENCES

[1] Yılmaz Ömer Çağlar, Ozkan Selçuk, Yavuz Bunyamin, et al. Masked hypertension is related to alteration of myocardial arrhythmia Parameters [J]. Clinical and Experimental Hypertension, 2021, 43(1):81-84.
[2] Zhang Ping, Zou Jing, Gao Cunzhou. Curative effect and safety of eplerenone in treatment of essential hypertension:a Meta-analysis [J]. Chinese Journal of Evidence-Based Cardiovascular Medicine, 2020, 12(11): 1324-1327+1331.
[3] Krokstad S. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants [J]. The Lancet, 2022(10324):399.
[4] Wang Zengwu, Chen Zuo, Zhang Linfeng, et al. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015 [J]. Circulation, 2018, 137(22):2344-2356.
[5] Hmwe Hmwe Kyu, Degu Abate, Kalkidan Hassen Abate, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. The Lancet, 2018, 392(10159):1859-1922.
[6] Elin Org, Margarete Mehrabian, Aldons J. Lusis, et al. Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota [J]. Atherosclerosis, 2015, 241(2):387-399.
[7] Romano Kymberleigh A, Vivas Eugenio I, Amador-Noguez Daniel, et al. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide [J]. mBio, 2015, 6(2):e02481.
[8] Hartley L, May MD, Loveman E, et al. Dietary fibre for the primary prevention of cardiovascular disease[J]. Cochrane Database of Systematic Reviews, 2016(1):CD011472.
[9] Anthony L. Komaroff. The Microbiome and Risk for Atherosclerosis [J]. JAMA, 2018, 319(23):2381-2382.
[10] Lewis CV, Taylor WR. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease.[J]. American journal of physiology [J]. Heart and circulatory physiology, 2020, 319(6):H1227-H1233.
[11] Zang Kaili, Jiang Yan, Sun Yong, et al. Probiotics Modulate the Structure and Abundance of Gut Mircrobiota in Populations with Intestinal Diseases [J]. Food Science, 2018, 39(13): 133-143.
[12] Zhang Yanwei, Lu Jianghao, Yan Mengjie, et al. Research on Probiotics to Improve Micro-ecosystem and Its Application [J]. Science and Technology of Food Industry, 2021, 42(04): 369-379.
[13] Shin Na Rae, Bose Shambhunath, Choi Yura, et al. Anti-Obesity Effect of Fermented Panax notoginseng Is Mediated Via Modulation of Appetite and Gut Microbial Population [J]. Frontiers in Pharmacology, 2021, 12:665881-665881.
[14] Geng Jiafeng, Ni Qingqiang, Sun Wei, et al. The links between gut microbiota and obesity and obesity related diseases [J]. Biomedicine & Pharmacotherapy, 2022, 147:112678-112678.
[15] Yang Lulu, Bajinka Ousman, Jarju Pa Omar, et al. The varying effects of antibiotics on gut microbiota [J]. AMB Express, 2021, 11(1):116-116.
[16] Del Fiol Fernando S, Balcão Victor M, Barberato-Fillho Silvio, et al. Obesity: A New Adverse Effect of Antibiotics? [J]. Frontiers in pharmacology, 2018, 9:1408.
[17] Soundharrajan Ilavenil, Kuppusamy Palaniselvam, Srisesharam Srigopalram, et al. Positive metabolic effects of selected probiotic bacteria on diet-induced obesity in mice are associated with improvement of dysbiotic gut microbiota [J]. FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 2020, 34(9):12289-12307.
[18] Jin Xiaoqin, Liu Bin, Liu Haoyuan, et al. Mechanism of Shenling Baizhu Powder in Treating Obesity Based on Intestinal Flora [J]. Acta Chinese Medicine, 2023, 38(08): 1732-1738.
[19] Vishal Singh, Benoit Chassaing, Limin Zhang, et al. Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice [J]. Cell Metabolism, 2015, 22(6):983-996.
[20] Li Cailiu, Jia Xiubin, Liu Yunchao, et al. Study on Effects of Polysaccharide from Cordyceps Taishanensis on Lipid Metabolism and Inflammatory Response in Livers of ob/ob Mice by Regulating Intestinal Floras [J]. Chinese Journal of Traditional Medical Science and Technology, 2023, 30(04): 662-665.
[21] Fu Jingyuan, Bonder Marc Jan, Cenit María Carmen, et al. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids [J]. Circulation research, 2015, 117(9):817-824.
[22] Liu Zuheng, et al. Moderate-Intensity Exercise Affects Gut Microbiome Composition and Influences Cardiac Function in Myocardial Infarction Mice [J]. Frontiers in Microbiology, 2017, 8:1687.
[23] Christian C Evans, Kathy J LePard, Jeff W Kwak, et al. Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesity [J]. PLoS ONE, 2017, 9(3):e92193.
[24] Campbell Sara C, Wisniewski Paul J, Noji Michael, et al. The Effect of Diet and Exercise on Intestinal Integrity and Microbial Diversity in Mice [J]. PloS one, 2016, 11(3):e0150502.
[25] Clark Allison, Mach Núria. Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes [J]. Journal of the International Society of Sports Nutrition, 2016, 13(1):43.
[26] Christie J. Bennett, Rebekah Henry, Rhiannon M.J. Snipe, et al. Is the gut microbiota bacterial abundance and composition associated with intestinal epithelial injury, systemic inflammatory profile, and gastrointestinal symptoms in response to exertional-heat stress? [J]. Journal of Science and Medicine in Sport, 2020, 23:1141-1153.
[27] Pasini Evasio, Corsetti Giovanni, Assanelli Deodato, et al. Effects of chronic exercise on gut microbiota and intestinal barrier in human with type 2 diabetes [J]. Minerva medica, 2019, 110(1):3-11.
[28] Ariel Bier, Tzipi Braun, Rawan Khasbab, et al. A High Salt Diet Modulates the Gut Microbiota and Short Chain Fatty Acids Production in a Salt-Sensitive Hypertension Rat Model [J]. Nutrients, 2018, 10(9):1154- 1154.
[29] Marques Francine Z, Nelson Erin, Chu Po-Yin, et al. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice [J]. Circulation, 2017, 135(10):964-977.
[30] Li Bo, He Xinglishang, Jin Haiying, et al. Beneficial effects of Dendrobium officinale on metabolic hypertensive rats by triggering the enteric-origin SCFA-GPCR43/41 pathway [J]. Food & function, 2021, 12(12):5524-5538.
[31] Zhong Lingyun, Deng Xiaoyan, Huang Yi, et al. Pharmacodynamics and intestinal flora research on different processed products of Puerariae Lobatae Radix and Puerariae Thomsonii Radix [J]. China Journal of Chinese Materia Medica, 2021, 46(17): 4403-4409.
[32] Han Cong, Jiang Yuehua, Li Wei, et al. Study on the mechanism of Astragalus and Salvia miltiorrhiza on intestinal flora of spontaneously hypertensive rats based on 16S rDNA sequencing technology [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2019, 34(05): 2233-2237.
[33] Anne-Mary Lewis-Mikhael, Amirhossein Davoodvandi, Sadegh Jafarnejad, et al. Effect of Lactobacillusplantarum containing probiotics on blood pressure: A systematic review and meta-analysis [J]. Pharmacological Research, 2020, 153:104663.
[34] Aoyagi Y, Park S, Matsubara S, et al. Habitual intake of fermented milk products containing Lactobacillus casei strain Shirota and a reduced risk of hypertension in older people [J]. Beneficial microbes, 2017, 8(1):23-29.
[35] Thushara Ram Mohan, Gangadaran Surendiran, Solati Zahra, et al. Cardiovascular benefits of probiotics: a review of experimental and clinical studies [J]. Food & function, 2016, 7(2):632-642.
[36] Jin Mengchao, Qian Zhiyuan, Yin Jiayu, et al. The role of intestinal microbiota in cardiovascular disease [J]. Journal of cellular and molecular medicine, 2019, 23(4):2343-2350.
[37] Upadrasta Aditya, Madempudi Ratna Sudha. Probiotics and blood pressure: current insights [J]. Integrated blood pressure control, 2016, 9:33-42.
[38] Curtis Huttenhower, Dirk Gevers, Rob Knight, et al. Structure, function and diversity of the healthy human microbiome [J]. Nature, 2012, 486(7402):207-214.
[39] Sharma Ravindra K, Yang Tao, Oliveira Aline C, et al. Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension [J]. Circulation research, 2019, 124(5):727-736.
[40] Galla S, Chakraborty S, Cheng X, et al. Disparate effects of antibiotics on hypertension.[J]. Physiological genomics, 2018, 50(10):837-845.

Subscription

E-Mail Alert

Downloads:	1831
Visits:	85851

Relationship between Hypertension and Gut Microbiota: A Comprehensive Review

Author(s)

Affiliation(s)

Corresponding Author

ABSTRACT

KEYWORDS

CITE THIS PAPER

REFERENCES

RESOURCES

JOIN US

PUBLICATION SERVICES

CONTACT US